Tumour-associated epilepsy: Clinical impact and the role of referring centres in a cohort of glioblastoma patients. A multicentre study from the Lombardia Neurooncology Group

Maurizio Riva, A. Salmaggi, E. Marchioni, A. Silvani, G. Tomei, L. Lorusso, R. Merli, F. Imbesi, A. Russo

Research output: Contribution to journalArticle

Abstract

Epilepsy in high-grade glioma patients is a major concern, mainly as regards indications to treatment and best choice; toxicities, and pharmocokinetic and pharmacodynamic interactions of drugs. All these generally unsolved problems complicate patients' quality of life and interfere with the evaluation of response criteria in clinical trials. A prospective, multicentre data collection on 132 adult newly diagnosed, histologically proven glioblastomas from 9 Lombardy hospitals collected in the same database during a one-year period was recently published. From this database we report epidemiological and clinical characteristics in epilepsy-symptomatic (31%) glioblastoma patients vs. the group with other presenting symptoms (69%). We analyse demographic and clinico-radiological features, timing of onset and the course of seizures, and modalities of treatment in the two groups of patients. No statistically significant differences were observed between the two groups as regards age, site of lesion(s), extent of surgery and survival in relation to anticonvulsant treatment status or pharmacokinetic properties of drugs.

Original languageEnglish
Pages (from-to)345-351
Number of pages7
JournalNeurological Sciences
Volume27
Issue number5
DOIs
Publication statusPublished - Nov 2006

Fingerprint

Glioblastoma
Multicenter Studies
Epilepsy
Neoplasms
Databases
Drug Interactions
Glioma
Anticonvulsants
Seizures
Therapeutics
Pharmacokinetics
Quality of Life
Demography
Clinical Trials
Survival
Pharmaceutical Preparations

Keywords

  • Epilepsy onset and treatment
  • Glioblastoma
  • Prospective multicentre study

ASJC Scopus subject areas

  • Neuroscience(all)
  • Clinical Neurology

Cite this

Tumour-associated epilepsy : Clinical impact and the role of referring centres in a cohort of glioblastoma patients. A multicentre study from the Lombardia Neurooncology Group. / Riva, Maurizio; Salmaggi, A.; Marchioni, E.; Silvani, A.; Tomei, G.; Lorusso, L.; Merli, R.; Imbesi, F.; Russo, A.

In: Neurological Sciences, Vol. 27, No. 5, 11.2006, p. 345-351.

Research output: Contribution to journalArticle

@article{ef4634cc03a14816a1c5abf8a9d1eca5,
title = "Tumour-associated epilepsy: Clinical impact and the role of referring centres in a cohort of glioblastoma patients. A multicentre study from the Lombardia Neurooncology Group",
abstract = "Epilepsy in high-grade glioma patients is a major concern, mainly as regards indications to treatment and best choice; toxicities, and pharmocokinetic and pharmacodynamic interactions of drugs. All these generally unsolved problems complicate patients' quality of life and interfere with the evaluation of response criteria in clinical trials. A prospective, multicentre data collection on 132 adult newly diagnosed, histologically proven glioblastomas from 9 Lombardy hospitals collected in the same database during a one-year period was recently published. From this database we report epidemiological and clinical characteristics in epilepsy-symptomatic (31{\%}) glioblastoma patients vs. the group with other presenting symptoms (69{\%}). We analyse demographic and clinico-radiological features, timing of onset and the course of seizures, and modalities of treatment in the two groups of patients. No statistically significant differences were observed between the two groups as regards age, site of lesion(s), extent of surgery and survival in relation to anticonvulsant treatment status or pharmacokinetic properties of drugs.",
keywords = "Epilepsy onset and treatment, Glioblastoma, Prospective multicentre study",
author = "Maurizio Riva and A. Salmaggi and E. Marchioni and A. Silvani and G. Tomei and L. Lorusso and R. Merli and F. Imbesi and A. Russo",
year = "2006",
month = "11",
doi = "10.1007/s10072-006-0708-6",
language = "English",
volume = "27",
pages = "345--351",
journal = "Neurological Sciences",
issn = "1590-1874",
publisher = "Springer-Verlag Italia s.r.l.",
number = "5",

}

TY - JOUR

T1 - Tumour-associated epilepsy

T2 - Clinical impact and the role of referring centres in a cohort of glioblastoma patients. A multicentre study from the Lombardia Neurooncology Group

AU - Riva, Maurizio

AU - Salmaggi, A.

AU - Marchioni, E.

AU - Silvani, A.

AU - Tomei, G.

AU - Lorusso, L.

AU - Merli, R.

AU - Imbesi, F.

AU - Russo, A.

PY - 2006/11

Y1 - 2006/11

N2 - Epilepsy in high-grade glioma patients is a major concern, mainly as regards indications to treatment and best choice; toxicities, and pharmocokinetic and pharmacodynamic interactions of drugs. All these generally unsolved problems complicate patients' quality of life and interfere with the evaluation of response criteria in clinical trials. A prospective, multicentre data collection on 132 adult newly diagnosed, histologically proven glioblastomas from 9 Lombardy hospitals collected in the same database during a one-year period was recently published. From this database we report epidemiological and clinical characteristics in epilepsy-symptomatic (31%) glioblastoma patients vs. the group with other presenting symptoms (69%). We analyse demographic and clinico-radiological features, timing of onset and the course of seizures, and modalities of treatment in the two groups of patients. No statistically significant differences were observed between the two groups as regards age, site of lesion(s), extent of surgery and survival in relation to anticonvulsant treatment status or pharmacokinetic properties of drugs.

AB - Epilepsy in high-grade glioma patients is a major concern, mainly as regards indications to treatment and best choice; toxicities, and pharmocokinetic and pharmacodynamic interactions of drugs. All these generally unsolved problems complicate patients' quality of life and interfere with the evaluation of response criteria in clinical trials. A prospective, multicentre data collection on 132 adult newly diagnosed, histologically proven glioblastomas from 9 Lombardy hospitals collected in the same database during a one-year period was recently published. From this database we report epidemiological and clinical characteristics in epilepsy-symptomatic (31%) glioblastoma patients vs. the group with other presenting symptoms (69%). We analyse demographic and clinico-radiological features, timing of onset and the course of seizures, and modalities of treatment in the two groups of patients. No statistically significant differences were observed between the two groups as regards age, site of lesion(s), extent of surgery and survival in relation to anticonvulsant treatment status or pharmacokinetic properties of drugs.

KW - Epilepsy onset and treatment

KW - Glioblastoma

KW - Prospective multicentre study

UR - http://www.scopus.com/inward/record.url?scp=34548626416&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34548626416&partnerID=8YFLogxK

U2 - 10.1007/s10072-006-0708-6

DO - 10.1007/s10072-006-0708-6

M3 - Article

C2 - 17122945

AN - SCOPUS:34548626416

VL - 27

SP - 345

EP - 351

JO - Neurological Sciences

JF - Neurological Sciences

SN - 1590-1874

IS - 5

ER -